Ebola: Over 2,000 Dead in DR Congo as Virus Gathers Pace

The Democratic Republic of Congo (DRC) is grappling with a devastating outbreak of the Bundibugyo Ebola virus, which has claimed over 2,000 lives since its first recorded case.The outbreak, now the 17th recorded in the country, has seen more than 4,380 infections recorded in total.The current strain is particularly virulent, with a case fatality rate of 45.9%, higher than the 39.6% recorded during the 2014-2016 West African outbreak, which was the deadliest on record.Sania Nishtar, of the Gavi global vaccine alliance, warns that this outbreak could become the largest ever, surpassing previous outbreaks.The pace of death is accelerating, with the virus spreading rapidly and exhibiting a higher mortality rate compared to previous outbreaks.The first transmissions likely occurred in February, and the 1,000-death mark was not reached until nine weeks in, doubling within just three weeks.The current outbreak was declared on May 15, but health authorities suspect the first transmissions may have occurred earlier.The case fatality rate is significantly higher than in previous outbreaks, raising concerns about the effectiveness of available vaccines and the need for urgent action.Health authorities face significant challenges due to the volatile security situation, poor infrastructure, and lack of healthcare worker support, making it difficult to contain the spread of the virus.Health Minister Samuel Roger Kamba anticipates that the spread will decline within three months, but the situation remains critical.Ebola, a highly infectious hemorrhagic fever transmitted through contact with bodily fluids, has claimed over 15,000 lives in Africa over the past five decades.The DRC authorities have imposed restrictions on public gatherings and closed the airport in Ituri Province, the outbreak's epicenter, to curb the virus's spread.While the World Health Organization (WHO) is actively working on trials for antiviral treatments, the Ervebo vaccine, though effective against the Zaire strain, has shown no proven efficacy against the Bundibugyo strain.The WHO is hopeful that the vaccine may offer some protection against the DRC strain.The outbreak's origins are believed to be an animal-to-human transmission, with the pathogen potentially mutating, according to researchers from Congo, Uganda, Belgium, and other countries.The Africa CDC warns that the virus's transmission may be outpacing contact tracing efforts, falling below the WHO's target of tracking 95% of potential contacts.